It has been 44 years since work toward a viable vaccine for respiratory syncytial virus began. But, after the inaugural roll-out of an RSV vaccine for older adults and a maternal vaccine to protect infants during the 2023-2024 viral season, new research and data have emerged.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
